The apheresis consumables and equipment market size has grown rapidly in recent years. It will grow from $3.76 billion in 2025 to $4.16 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to limited automation in apheresis procedures, reliance on manual devices, growing awareness of hematology and renal disease management, increasing blood donation drives, conventional filtration and separation methods.
The apheresis consumables and equipment market size is expected to see rapid growth in the next few years. It will grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to technological advancements in automated apheresis devices, rising demand for plasma-derived therapies, expansion of stem cell collection procedures, increasing regulatory compliance for disposables and devices, integration with digital monitoring and IoT-enabled systems. Major trends in the forecast period include rising demand for automated apheresis devices, increased use of disposable kits and tubing sets, expansion of plasma and plateletpheresis procedures, adoption of advanced centrifugation and membrane filtration technologies, growing focus on patient safety and blood component quality.
The incidence of blood disorders is increasing worldwide, creating a greater need for blood transfusions. Apheresis equipment is used to transfuse blood for blood disorders such as sickle cell anemia, leukemia, and cancer. According to a report published by the Leukemia and Lymphoma Society, 60,300 people in the USA are expected to be diagnosed with leukemia, and one individual is diagnosed with blood cancer every 3 minutes, requiring immediate blood transfusion. According to the American Society of Hematology, approximately 100,000 Americans have sickle cell anemia, and an additional 2 million people carry the trait, necessitating the use of apheresis equipment for blood transfusion. Furthermore, according to the International Agency for Research on Cancer (IARC), 16.3 million new cancer cases are projected to be reported globally by 2040. Cancer treatment requires at least 8 units of blood per patient per procedure, thereby increasing the need for blood component collection and transfusion. Thus, the high prevalence of these blood disorders is boosting demand for the apheresis consumables and equipment industry.
The increasing prevalence of chronic conditions is expected to drive growth in the apheresis consumables and equipment market going forward. Chronic conditions, also referred to as chronic diseases, are long-term health issues that persist for extended periods, often throughout a person’s lifetime, and generally cannot be fully cured. Apheresis consumables and equipment play an essential role in managing chronic diseases by enabling the targeted removal or collection of blood components in conditions such as autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvesting. For example, in 2023, according to the National Library of Medicine, a US-based government medical library, nearly 36% of US adults aged 50 and older are projected to have at least one chronic condition by 2035, with the proportion expected to increase to nearly 48% by 2050. As a result, the rising burden of chronic conditions is contributing to the expansion of the apheresis consumables and equipment market.
Major companies operating in the apheresis consumables and equipment market are introducing new offerings, such as the Amicus extracorporeal photopheresis single-needle option, to provide more versatile therapy solutions. The Amicus Extracorporeal Photopheresis single-needle option is an enhanced feature of the Amicus Extracorporeal Photopheresis (ECP) System that enables the collection and return of blood components through a single venous access point during photopheresis procedures. For example, in April 2023, Fresenius Kabi, a Germany-based healthcare company, launched the single-needle option for the Amicus ECP System. The update includes new software versions for the Amicus Separator and the Phelix Photoactivation Device, along with a disposable kit supporting either single- or double-needle venous access. This enhancement enables more flexible treatment options, particularly benefiting patients with limited venous access. The system’s primary therapeutic use is extracorporeal photopheresis, a leukapheresis-based treatment for cutaneous T-cell lymphoma (CTCL).
Major companies operating in the apheresis consumables and equipment market are Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Kawasumi Laboratories Inc., Fresenius SE & Co. KGaA, Terumo BCT, Braun Melsungen AG, Therakos Inc., HemaCare Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Medica SpA, Terumo Corporation, Macopharma, Grifols S.A., Baxter International Inc., Fenwal Inc., Miltenyi Biotec GmbH, Infomed SA, Lmb Technologie GmbH, Medivators Inc., Nigale Biomedical Inc., Aferetica S.r.l., Apheresis Care Group, Beijing Meso-Tech Co. Ltd., Biegler GmbH, Brightwake Ltd., Cytosorbents Corporation, DePuy Synthes Companies, Guangzhou Daji Medical Science and Technology Co. Ltd., Haier Biomedical.
North America was the largest region in the apheresis consumables and equipment market in 2025. Western Europe was the second-largest region in the global apheresis consumables and equipment market share. The regions covered in the apheresis consumables and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the apheresis consumables and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the apheresis consumables and equipment market by increasing the cost of imported devices, disposables, and filtration components. Segments like automated apheresis devices and centrifuges are particularly impacted, with regions such as Asia-Pacific and Europe facing higher import duties. This has led to increased operational costs and supply chain adjustments for manufacturers and healthcare providers. On the positive side, tariffs have encouraged local manufacturing, development of cost-effective alternatives, and innovation in domestic production capabilities.
The apheresis consumables and equipment market research report is one of a series of new reports that provides apheresis consumables and equipment market statistics, including apheresis consumables and equipment industry global market size, regional shares, competitors with a apheresis consumables and equipment market share, detailed apheresis consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis consumables and equipment industry. This apheresis consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Apheresis consumables and equipment are medical devices used to separate blood drawn from a donor into its different components through techniques such as plasma exchange, stem cell collection, photopheresis, and low-density lipid removal. The required components, such as plasma or platelets, are retained while the remaining blood is returned to the donor’s circulation.
The major products in apheresis consumables and equipment include disposables and devices. Apheresis consumables are items utilized in the process of apheresis technology. The technologies used in disposables and devices include centrifugation and membrane filtration, while the procedures involve photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others. Apheresis consumables and equipment are applied in therapeutic areas such as renal disease, neurology, hematology, and others.
The apheresis consumables and equipment market consists of sales of equipment and consumables. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The apheresis consumables and equipment market size is expected to see rapid growth in the next few years. It will grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to technological advancements in automated apheresis devices, rising demand for plasma-derived therapies, expansion of stem cell collection procedures, increasing regulatory compliance for disposables and devices, integration with digital monitoring and IoT-enabled systems. Major trends in the forecast period include rising demand for automated apheresis devices, increased use of disposable kits and tubing sets, expansion of plasma and plateletpheresis procedures, adoption of advanced centrifugation and membrane filtration technologies, growing focus on patient safety and blood component quality.
The incidence of blood disorders is increasing worldwide, creating a greater need for blood transfusions. Apheresis equipment is used to transfuse blood for blood disorders such as sickle cell anemia, leukemia, and cancer. According to a report published by the Leukemia and Lymphoma Society, 60,300 people in the USA are expected to be diagnosed with leukemia, and one individual is diagnosed with blood cancer every 3 minutes, requiring immediate blood transfusion. According to the American Society of Hematology, approximately 100,000 Americans have sickle cell anemia, and an additional 2 million people carry the trait, necessitating the use of apheresis equipment for blood transfusion. Furthermore, according to the International Agency for Research on Cancer (IARC), 16.3 million new cancer cases are projected to be reported globally by 2040. Cancer treatment requires at least 8 units of blood per patient per procedure, thereby increasing the need for blood component collection and transfusion. Thus, the high prevalence of these blood disorders is boosting demand for the apheresis consumables and equipment industry.
The increasing prevalence of chronic conditions is expected to drive growth in the apheresis consumables and equipment market going forward. Chronic conditions, also referred to as chronic diseases, are long-term health issues that persist for extended periods, often throughout a person’s lifetime, and generally cannot be fully cured. Apheresis consumables and equipment play an essential role in managing chronic diseases by enabling the targeted removal or collection of blood components in conditions such as autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvesting. For example, in 2023, according to the National Library of Medicine, a US-based government medical library, nearly 36% of US adults aged 50 and older are projected to have at least one chronic condition by 2035, with the proportion expected to increase to nearly 48% by 2050. As a result, the rising burden of chronic conditions is contributing to the expansion of the apheresis consumables and equipment market.
Major companies operating in the apheresis consumables and equipment market are introducing new offerings, such as the Amicus extracorporeal photopheresis single-needle option, to provide more versatile therapy solutions. The Amicus Extracorporeal Photopheresis single-needle option is an enhanced feature of the Amicus Extracorporeal Photopheresis (ECP) System that enables the collection and return of blood components through a single venous access point during photopheresis procedures. For example, in April 2023, Fresenius Kabi, a Germany-based healthcare company, launched the single-needle option for the Amicus ECP System. The update includes new software versions for the Amicus Separator and the Phelix Photoactivation Device, along with a disposable kit supporting either single- or double-needle venous access. This enhancement enables more flexible treatment options, particularly benefiting patients with limited venous access. The system’s primary therapeutic use is extracorporeal photopheresis, a leukapheresis-based treatment for cutaneous T-cell lymphoma (CTCL).
Major companies operating in the apheresis consumables and equipment market are Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Kawasumi Laboratories Inc., Fresenius SE & Co. KGaA, Terumo BCT, Braun Melsungen AG, Therakos Inc., HemaCare Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Medica SpA, Terumo Corporation, Macopharma, Grifols S.A., Baxter International Inc., Fenwal Inc., Miltenyi Biotec GmbH, Infomed SA, Lmb Technologie GmbH, Medivators Inc., Nigale Biomedical Inc., Aferetica S.r.l., Apheresis Care Group, Beijing Meso-Tech Co. Ltd., Biegler GmbH, Brightwake Ltd., Cytosorbents Corporation, DePuy Synthes Companies, Guangzhou Daji Medical Science and Technology Co. Ltd., Haier Biomedical.
North America was the largest region in the apheresis consumables and equipment market in 2025. Western Europe was the second-largest region in the global apheresis consumables and equipment market share. The regions covered in the apheresis consumables and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the apheresis consumables and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the apheresis consumables and equipment market by increasing the cost of imported devices, disposables, and filtration components. Segments like automated apheresis devices and centrifuges are particularly impacted, with regions such as Asia-Pacific and Europe facing higher import duties. This has led to increased operational costs and supply chain adjustments for manufacturers and healthcare providers. On the positive side, tariffs have encouraged local manufacturing, development of cost-effective alternatives, and innovation in domestic production capabilities.
The apheresis consumables and equipment market research report is one of a series of new reports that provides apheresis consumables and equipment market statistics, including apheresis consumables and equipment industry global market size, regional shares, competitors with a apheresis consumables and equipment market share, detailed apheresis consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis consumables and equipment industry. This apheresis consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Apheresis consumables and equipment are medical devices used to separate blood drawn from a donor into its different components through techniques such as plasma exchange, stem cell collection, photopheresis, and low-density lipid removal. The required components, such as plasma or platelets, are retained while the remaining blood is returned to the donor’s circulation.
The major products in apheresis consumables and equipment include disposables and devices. Apheresis consumables are items utilized in the process of apheresis technology. The technologies used in disposables and devices include centrifugation and membrane filtration, while the procedures involve photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others. Apheresis consumables and equipment are applied in therapeutic areas such as renal disease, neurology, hematology, and others.
The apheresis consumables and equipment market consists of sales of equipment and consumables. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Apheresis Consumables and Equipment Market Characteristics
3. Apheresis Consumables and Equipment Market Supply Chain Analysis
4. Global Apheresis Consumables and Equipment Market Trends and Strategies
5. Apheresis Consumables and Equipment Market Analysis of End Use Industries
7. Global Apheresis Consumables and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Apheresis Consumables and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Apheresis Consumables and Equipment Market Segmentation
10. Apheresis Consumables and Equipment Market Regional and Country Analysis
11. Asia-Pacific Apheresis Consumables and Equipment Market
12. China Apheresis Consumables and Equipment Market
13. India Apheresis Consumables and Equipment Market
14. Japan Apheresis Consumables and Equipment Market
15. Australia Apheresis Consumables and Equipment Market
16. Indonesia Apheresis Consumables and Equipment Market
17. South Korea Apheresis Consumables and Equipment Market
18. Taiwan Apheresis Consumables and Equipment Market
19. South East Asia Apheresis Consumables and Equipment Market
20. Western Europe Apheresis Consumables and Equipment Market
21. UK Apheresis Consumables and Equipment Market
22. Germany Apheresis Consumables and Equipment Market
23. France Apheresis Consumables and Equipment Market
24. Italy Apheresis Consumables and Equipment Market
25. Spain Apheresis Consumables and Equipment Market
26. Eastern Europe Apheresis Consumables and Equipment Market
27. Russia Apheresis Consumables and Equipment Market
28. North America Apheresis Consumables and Equipment Market
29. USA Apheresis Consumables and Equipment Market
30. Canada Apheresis Consumables and Equipment Market
31. South America Apheresis Consumables and Equipment Market
32. Brazil Apheresis Consumables and Equipment Market
33. Middle East Apheresis Consumables and Equipment Market
34. Africa Apheresis Consumables and Equipment Market
36. Apheresis Consumables and Equipment Market Competitive Landscape and Company Profiles
37. Apheresis Consumables and Equipment Market Other Major and Innovative Companies
40. Apheresis Consumables and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Apheresis Consumables And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses apheresis consumables and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for apheresis consumables and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The apheresis consumables and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Disposables; Devices2) By Technology: Centrifugation; Membrane Filtration
3) By Procedure: Photopheresis; Plasmapheresis; LDL Apheresis; Plateletpheresis; Leukapheresis; Erythrocytapheresis; Other Procedures
4) By Application: Renal Disease; Neurology; Hematology; Other Applications
Subsegments:
1) By Disposables: Apheresis Kits; Tubing Sets; Filters; Collection Bags; Anticoagulants2) By Devices: Automated Apheresis Devices; Manual Apheresis Devices; Centrifuges; Plasmapheresis Devices
Companies Mentioned: Asahi Kasei Medical Co. Ltd.; Haemonetics Corporation; Kawasumi Laboratories Inc.; Fresenius SE & Co. KGaA; Terumo BCT; Braun Melsungen AG; Therakos Inc.; HemaCare Corporation; Cerus Corporation; Kaneka Corporation; Nikkiso Co.; Medica SpA; Terumo Corporation; Macopharma; Grifols S.A.; Baxter International Inc.; Fenwal Inc.; Miltenyi Biotec GmbH; Infomed SA; Lmb Technologie GmbH; Medivators Inc.; Nigale Biomedical Inc.; Aferetica S.r.l.; Apheresis Care Group; Beijing Meso-Tech Co. Ltd.; Biegler GmbH; Brightwake Ltd.; Cytosorbents Corporation; DePuy Synthes Companies; Guangzhou Daji Medical Science and Technology Co. Ltd.; Haier Biomedical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Apheresis Consumables and Equipment market report include:- Asahi Kasei Medical Co. Ltd.
- Haemonetics Corporation
- Kawasumi Laboratories Inc.
- Fresenius SE & Co. KGaA
- Terumo BCT
- Braun Melsungen AG
- Therakos Inc.
- HemaCare Corporation
- Cerus Corporation
- Kaneka Corporation
- Nikkiso Co.
- Medica SpA
- Terumo Corporation
- Macopharma
- Grifols S.A.
- Baxter International Inc.
- Fenwal Inc.
- Miltenyi Biotec GmbH
- Infomed SA
- Lmb Technologie GmbH
- Medivators Inc.
- Nigale Biomedical Inc.
- Aferetica S.r.l.
- Apheresis Care Group
- Beijing Meso-Tech Co. Ltd.
- Biegler GmbH
- Brightwake Ltd.
- Cytosorbents Corporation
- DePuy Synthes Companies
- Guangzhou Daji Medical Science and Technology Co. Ltd.
- Haier Biomedical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.16 Billion |
| Forecasted Market Value ( USD | $ 6.29 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
